Tuesday, November 10, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Rare Eye Condition Prompts New FDA Warning On Popular GLP-1 Drugs

TUESDAY, Nov. 10, 2026 — The U.S. Food and Drug Administration (FDA) is requiring makers of Ozempic, Wegovy and similar drugs to warn of a rare eye condition that can cause vision…

DO
By Daniel Okafor · Regulatory Correspondent
Nov 10 10:30 ETSource: Drugs.com

From the source

Rare Eye Condition Prompts New FDA Warning On Popular GLP-1 Drugs

TUESDAY, Nov. 10, 2026 — The U.S. Food and Drug Administration (FDA) is requiring makers of Ozempic, Wegovy and similar drugs to warn of a rare eye condition that can cause vision loss.The condition is called non-arteritic anterior ischemic optic...

Read at drugs.com
PeptiPrescribed peptides from $99/moSee all →